Stockholders' Equity (Details) - USD ($)									1 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	Jul. 02, 2022	Jul. 02, 2021	Jun. 04, 2021	May 13, 2021	Feb. 12, 2021	Nov. 03, 2020	Jul. 02, 2020	Jul. 01, 2020	Feb. 18, 2021	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Jun. 02, 2021	Oct. 08, 2020
Stockholders' Equity (Details) [Line Items]
Increase of authorized shares, description						the Company’s stockholders approved an amendment to the Company’s charter to increase the authorized shares of Common Stock from 100,000,000 to 300,000,000. Consequently, the Company’s charter allows the Company to issue up to 300,000,000 shares of Common Stock and to issue and designate its rights, without stockholder approval, of up to 5,000,000 shares of preferred stock, par value $0.0001.
Preferred stock, shares authorized										4,932,200		4,932,200	4,932,200
Preferred stock, shares outstanding
Dividend payment terms												The 7.00% Series B Convertible Preferred Stock accrues dividends at a rate of 7% per annum, whether or not declared. Of the 7.00% dividends, 4% is paid regularly, while 3% is paid at the Automatic Conversion Date.
Common stock, par value (in Dollars per share)										$ 0.0001		$ 0.0001	$ 0.0001
Shares issued								1,801,851		1.421333		1.421333
Aggregate offering price (in Dollars)											$ 50,000,000
Sale of shares												1,700,000
Net proceeds (in Dollars)												$ 3,500,000
Restricted stock shares	238,643	238,643					238,643					106,840
Warrants exercised												16,775,143
Exercise price (in Dollars per share)										$ 1.4		$ 1.4
Cash proceeds from warrants exercises (in Dollars)												$ 23,485,200
Proceeds from warrant liability (in Dollars)												$ 53,518,942
Shares issued										97,563,841		97,563,841	64,091,266
Gross proceeds (in Dollars)					$ 34,500,000
Preferred stock and warrants to purchase common stock, description			the Company and IRG, LLC, as assigned by IRG, LLC to CH Capital Lending, LLC, and the binding term sheet dated January 28, 2021, the Company issued and sold to CH Capital Lending, LLC for a purchase price of $15 million in a private placement (the “New Private Placement”) (i) 15,000 shares of Series B Preferred Stock, which are convertible into shares of Common Stock, having an aggregate liquidation preference of $15 million plus any accrued but unpaid dividends to the date of payment, and (ii) 2,450,980 Series D Warrants, with a term of three years, exercisable six months after issuance, each exercisable for one share of Common Stock at an exercise price of $6.90 per share, subject to certain adjustments. Also on June 4, 2021, the Company closed a securities purchase agreement with another purchaser for 200 shares of Series B Preferred Stock and 32,680 Series D Warrants.
Restricted Stock Awards [Member]
Stockholders' Equity (Details) [Line Items]
Restricted stock shares												66,451
Restricted Stock Awards [Member] | Chief Executive Officer [Member]
Stockholders' Equity (Details) [Line Items]
Restricted stock shares													715,929
Vested [Member]
Stockholders' Equity (Details) [Line Items]
Restricted stock shares							238,643
Restricted Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Stock–based compensation related to restricted stock (in Dollars)										$ 2,436,091			$ 3,327,280
Stock-based compensation expense (in Dollars)													2,218,187
Related to restricted share arrangements (in Dollars)												$ 1,109,093
Weighted average period												6 months
Restricted Stock Units [Member]
Stockholders' Equity (Details) [Line Items]
Stock–based compensation related to restricted stock (in Dollars)												$ 3,074,043	$ 1,003,255
Related to restricted share arrangements (in Dollars)												$ 3,559,537
Weighted average period												1 year 3 months 18 days
Equity Distribution Agreement [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate offering price (in Dollars)												$ 50,000,000
Sale of shares										1,700,000
Net proceeds (in Dollars)										$ 3,500,000
Remaining availability of equity distribution (in Dollars)										$ 46,500,000
Director [Member] | Restricted Stock Units [Member]
Stockholders' Equity (Details) [Line Items]
Restricted stock shares												1,734,197
Director [Member] | Restricted Stock Units [Member] | Employees [Member]
Stockholders' Equity (Details) [Line Items]
Restricted stock shares													1,676,447
Series B Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized				15,200
Relative rights, percentage				7.00%
Series B Convertible Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized										15,200		15,200	0
Preferred stock, shares outstanding										15,200		15,200	0
Convertible preferred stock, percentage												7.00%
Minimum [Member] | Restricted Stock Units [Member]
Stockholders' Equity (Details) [Line Items]
Issuance of restricted stock units per share (in Dollars per share)										$ 1.98		$ 1.98	$ 1.3
Maximum [Member] | Restricted Stock Units [Member]
Stockholders' Equity (Details) [Line Items]
Issuance of restricted stock units per share (in Dollars per share)										$ 5.29		$ 5.29	$ 4.67
2020 Omnibus Incentive Plan [Member]
Stockholders' Equity (Details) [Line Items]
Common stock authorized for issuance shares								1,812,727
Common stock, par value (in Dollars per share)														$ 0.0001
Shares issued														5,812,727
Shares remained available for issuance										2,500,347		2,500,347
February 2021 Public Offering and Over-allotment [Member]
Stockholders' Equity (Details) [Line Items]
Shares issued					12,244,897
Price per share (in Dollars per share)					$ 2.45				$ 2.45
Additional shares of common stock									1,836,734
Outstanding common stock, percentage					5.00%
Authorized Capital [Member] | Series A Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized															52,800